Efficacy of entecavir in nucleoside-naïve patients with hepatitis B e antigen-positive chronic hepatitis B

World Chinese Journal of Digestology

Volumn 17, Issue 27, 2009, Pages 2846-2849

  Zhang, Quan ^a   Cheng, Ming Liang ^a   Liu, Qin ^a   Mu, Mao ^a   Zhang, Ying Ying ^a   Liu, Bi Yun ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B; Hepatitis B e antigen; Treatment

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; NUCLEOSIDE; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; SEROCONVERSION; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 75149192253     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i27.2846     Document Type: Article

References (15)

1. WHO. Hepatitis B. World Health Organization online. 2008-08, cited: 2009-05. Avaibale from: http://www.who.int/mediacentre/factsheets/ fs204/en/index.html
2. Chinese source
3. Chinese source
4. Keef fe EB, Dieter ich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006; 4: 936-962
5. Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, Gane E, Kao JH, Omata M; Asian-Pacific consensus update working party on chronic hepatitis B. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 2005; 25: 472-489
6. Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, Lok AS, Han KH, Goodman Z, Zhu J, Cross A, DeHertogh D, Wilber R, Colonno R, Apelian D. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006; 354: 1001-1010
7. [Guidelines for diagnosis and treatment of alcoholic liver diseases] Zhonghua Ganzangbing Zazhi 2006; 14: 164-166
8. Marcellin P, Chang TT, Lim SG, Sievert W, Tong M, Arterburn S, Borroto-Esoda K, Frederick D, Rousseau F. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2008; 48: 750-758
9. Chinese source
10. Chinese source
11. Chinese source
12. Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808-816
13. Chinese source
14. Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Wichroski MJ, Xu D, Yang J, Wilber RB, Colonno RJ. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. Hepatology 2009; 49: 1503-1514
15. Chinese source